25 Jun 2015 05:15
Clinical research and development group Venn Life Sciences Holdings has confirmed Jonathan Hartshorn has begun his tenure as the group's new chief financial officer. The London-listed company had appointed Hartshorn, who left his role as head of finance for the onshore division of Mainstream Renewab
Read more